Skip to content
healthcare.dev

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

NDC 58118-8020, Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, tablet, from Clinical Solutions Wholesale, LLC.

Product NDC
58118-8020
Status
Listed
Labeler
Clinical Solutions Wholesale, LLC
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207000
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58118-8020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
58118-8020-85811880200830 TABLET in 1 BLISTER PACK (58118-8020-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/273b79ac-2c62-4407-9cd1-2a2964ef13ba

Use it

Look up 58118-8020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58118-8020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58118-8020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.